Cabot has setback in mercury abatement | October 16, 2017 Issue - Vol. 95 Issue 41 | Chemical & Engineering News
Volume 95 Issue 41 | p. 16 | Concentrates
Issue Date: October 16, 2017

Cabot has setback in mercury abatement

Department: Business
Keywords: Oncology, immunotherapy, oncolytic virus, AbbVie, Turnstone Biologics

Cabot Corp. has indefinitely idled three of the seven production lines at its activated carbon plant in Marshall, Texas. Cabot and other activated carbon producers have been anticipating increased demand for the material to capture power-plant mercury after implementation of the Mercury & Air Toxics Standards regulation in the U.S. However, Cabot says demand for activated carbon has been lower than originally expected. The decision will affect 40 employees.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment